Periprocedural Short/Ultrashort-Acting β-Blockers in the Electrophysiology Laboratory for Some Patients to Prevent Takotsubo Syndrome?

Abstract This communication proposes the periprocedural use of intravenous short/ultrashort-acting β-blockers, in the course of invasive electrophysiologic procedures in general, to prevent the emergence of Takotsubo syndrome in seemingly susceptible patients. Such infusions could be stopped with impunity if the use of epinephrine or isoproterenol is deemed necessary as part of the implemented electrophysiology protocol or if side effects arise.